Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. - Archive ouverte HAL Access content directly
Journal Articles Contributions to Nephrology Year : 2008

Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy.

(1) , (2) , (2) , (2) , (1) , (1)
1
2

Abstract

An important issue in congenital unilateral ureteropelvic junction (UPJ) obstruction, a frequent pathology in newborns, is whether infants should undergo surgery. Non-invasive biomarkers to reduce or replace the current invasive clinical exploration are not available. The objective of this study was to identify urinary markers of UPJ obstruction. We compared a number of proteome technologies to study the urinary proteome in UPJ obstruction and selected online capillary electrophoresis coupled to mass-spectrometry for the selection of non-invasive prognostic biomarkers. We selected 53 urinary biomarkers that were able to distinguish between different levels of UPJ obstruction. In a prospective study using these 53 biomarkers, we predicted with 97% accuracy, and several months in advance, the clinical outcome of 36 UPJ-obstruction patients. Some of the discriminating biomarkers were identified. A newly identified marker, proSAAS (proprotein convertase subtilisin/kexin type 1 inhibitor), generated a new hypothesis in the physiopathology of UPJ obstruction. These results show that analysis of urinary polypeptides in newborns with UPJ obstruction can predict their clinical outcome.
Not file

Dates and versions

inserm-00408927 , version 1 (04-08-2009)

Identifiers

Cite

Stephane Decramer, Petra Zurbig, Stefan Wittke, Harald Mischak, Jean-Loup Bascands, et al.. Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy.. Contributions to Nephrology, 2008, 160, pp.127-41. ⟨10.1159/000125956⟩. ⟨inserm-00408927⟩
127 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More